Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2026-01-03 @ 4:38 AM
Study NCT ID:
NCT03373435
Status:
COMPLETED
Last Update Posted:
2022-07-18
First Post:
2017-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia
Sponsor:
Eiger BioPharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EIG-EXD-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None